Company Filing History:
Years Active: 2006-2010
Title: Eric Raspe: Innovator in Lipid Metabolism and Atherosclerosis Treatment
Introduction
Eric Raspe is a notable inventor based in Mouscron, Belgium. He has made significant contributions to the field of lipid metabolism and atherosclerosis treatment through his innovative patents. With a total of two patents to his name, Raspe's work focuses on the use of specific receptors to screen substances that can aid in treating lipid metabolism dysfunctions.
Latest Patents
Raspe's latest patents include the use of the Rev-erb family of receptors in screening substances useful for treating lipid metabolism dysfunctions associated with apolipoprotein C-III. This invention outlines methods for selecting substances that can be beneficial in treating these dysfunctions. Additionally, it discusses the use of screening tests to characterize and justify the mechanism of action of substances with anti-atherosclerotic properties. His other patent involves the use of ROR receptors for screening substances that possess antiatherosclerotic properties, further emphasizing his focus on cardiovascular health.
Career Highlights
Throughout his career, Eric Raspe has worked with prominent companies in the pharmaceutical industry, including Merck Patent Gesellschaft and Merck Patent GmbH. His experience in these organizations has contributed to his expertise in patent development and innovation in the medical field.
Collaborations
Raspe has collaborated with various professionals in his field, including Yves Bonhomme, enhancing the scope and impact of his research and inventions.
Conclusion
Eric Raspe's contributions to the field of lipid metabolism and atherosclerosis treatment through his innovative patents highlight his role as a significant inventor. His work continues to pave the way for advancements in therapeutic compositions aimed at improving cardiovascular health.